Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
AF Symposium 2024
Start date: Feb 01, 2024 End date: Feb 03, 2024
The 29th Annual International AF Symposium is taking place from February 1st to 3rd, 2024, at the Omni Boston Hotel at the Seaport. This symposium, initiated in 1995 to combat the growing epidemic of atrial fibrillation, has evolved into a premier scientific forum. Here, healthcare professionals gain exclusive access to cutting-edge research and therapeutic advancements from leading investigators… View more

Electrophysiology & Arrhythmia
ESC 23: MULTISTARS AMI Trial
Author(s): Linda Joosten Added: 7 months ago
ESC 2023 — Dr Linda Joosten (Julius Center for Health Sciences and Primary Care, NL) joins us to discuss the findings of the FRAIL-AF trial. FRAIL-AF is a multicentre, open-label randomised controlled clinical trial which studied frail elderly patients who receive vitamin K antagonist (VKA) treatment for atrial fibrillation (AF). Current clinical guidelines recommend non-vitamin K antagonists … View more

Anticoagulation

Demographic
Author(s): Emile Daoud , Dhanunjaya Lakkireddy , Mohit K Turagam , et al Added: 2 months ago
Short, accessibleExpert Interviewswere conducted with investigators focusing on study design, key results and applicability of the latest data. View more

Electrophysiology & Arrhythmia
ESC 2020: Edoxaban for Elderly AF Patients — Dr Ken Okumura
Author(s): Ken Okumura Added: 3 years ago
Dr Ken Okumura (Saiseikai Kumamoto Hospital, Kumamoto, JP) discusses the rationale and results behind ELDERCARE-AF, which investigates low dose Edoxaban for elderly Japanese AF patients ineligible for standard anticoagulant therapy. Questions: 1. What is the rationale for this study? 2. What were the objectives of this study, and its design? 3. What patients were included in the study? 4. What… View more

Anticoagulation

Electrophysiology & Arrhythmia
ACC 22: Results from the PACIFIC AF Trial
Author(s): Manesh R Patel Added: 2 years ago
In this short interview from our coverage of ACC.22 late-breaking trials, Dr Manesh Patel (Duke Heart Center, US) discusses the multicentre, randomised, double-blind PACIFIC-AF trial (Bayer)(NCT04218266). The trial sought to determine the efficacy of the oral FXIa inhibitor asundexian and evaluate the safety of the drug, compared to the non-vitamin K oral anticoagulant (NOAC) apixaban, in… View more

Anticoagulation

Electrophysiology & Arrhythmia
TCT 23: WATCH-TAVR: WATCHMAN for Patients with AF Undergoing TAVR
Author(s): Samir R Kapadia Added: 5 months ago
TCT 23 - We are joined by Dr Samir Kapadia (Cleveland Clinic, Cleveland, OH) to discuss the findings of the WATCH-TAVR Trial (NCT03173534). WATCH-TAVR aimed to evaluate the safety and effectiveness of left atrial appendage occlusion with the WATCHMAN device to prevent stroke and bleeding in patients with atrial fibrillation (AF) who are undergoing transcatheter aortic valve replacement (TAVR)… View more

Electrophysiology & Arrhythmia

Intervention
EHRA 24: Ablation Strategies for Repeat Procedures in Recurrent AF
Author(s): Boris Schmidt Added: 23 hours ago
EHRA 24 - Investigator, Dr Boris Schmidt (Cardioangiologisches Centrum Bethanien, DE) is interviewed on ablation strategies for repeat procedures in patients with recurrent atrial fibrillation (AF).The ASTRO trial is a multi-centre prospective randomized study that enrolled 256 patients with drug-refractory AF despite previous AF ablation. The trial showed no statistically significant differences… View more

Electrophysiology & Arrhythmia
Protecting AF Patients From Stroke: Guideline Updates and Management of Comorbidities
Author(s): Chi-Keong Ching , Reinhold Kreutz , Ian Phoon , et al Added: 3 years ago
Reproduced with permission from The Asia Pacific Society of Cardiology.Radcliffe have received no funding for the hosting of this content. View more

Anticoagulation
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF
Author(s): Naima Maqsood , Christian Ruff Added: 5 months ago
AHA 23 - Dr Naima Maqsood, CardioNerds ambassador (Temple University Hospital, US) interviews Dr Christian Ruff (Brigham and Women's Hospital, US) on the late-breaking findings from the AZALEA-TIMI 71 randomized trial (Anthos Theraputics, Inc).AZALEA-TIMI 71 aimed to evaluate the bleeding profile of abelacimab as compared to rivaroxaban in patients with atrial fibrillation who are at moderate to… View more

Anticoagulation

Electrophysiology & Arrhythmia
EHRA 24: The Style-AF Study
Author(s): Roland R Tilz Added: 4 days ago
EHRA 24 - We are joined onsite by Dr Roland Tilz (University Heart Center, DE) to discuss the findings of the Style-AF study (NCT05563142).This prospective, randomized, controlled study aims to compare the safety and efficacy of the Perclose ProStyle suture-medicated closure device to manual compression for the treatment of hemostasis after single-shot-device pulmonary vein isolation (PVI). 125… View more

Vascular Disease and Surgery

Electrophysiology & Arrhythmia